Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026936 · ClinicalTrials.gov registry record · Phase 2

A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning

A Phase 2 study of Neoplasm, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 2
Development phase
140
Enrollment target
1
Study location

NCT00026936 is a Phase 2 study of Neoplasm that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 140 participants, below the 190-participant average among 11 other Neoplasm trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026936, a Phase 2 study of Neoplasm, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 2
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a clinical setting will be assessed by comparing results with other fully three-dimensional programs. ROB will investigate PEREGRINE for clinical use at NCI in collaboration with Lawrence Livermore National Laboratory (LLNL).

Conditions Studied

Neoplasm

Interventions

  • PROCEDURE Radiotherapy

Study Locations (1)

Maryland

  • National Cancer Institute (NCI) - Bethesda

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 1999-05
Est. Completion 2005-01
Phase Phase 2

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00026936

The ClinicalTrials.gov registry entry for NCT00026936 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 11 other Neoplasm trials with a reported enrollment target (26% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Radiotherapy is the first listed.

NCT00026936 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00026936 about?

NCT00026936 is a clinical study titled "A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning". The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a clinical setting will be assessed by comparing results with other fully three-dimensional programs. ROB will investigate PEREGRINE for clinical use at NCI in collaboration with Lawrence Livermore National Laborat...

What is the current status of trial NCT00026936?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 1999-05. Estimated completion is 2005-01.

What conditions does trial NCT00026936 study?

This clinical trial studies the following conditions: Neoplasm.

What interventions are being tested in trial NCT00026936?

The interventions under investigation include: Radiotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT00026936?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00026936 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neoplasm

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.